Treatment of major depressive disorder in the Finnish general population
✍ Scribed by Juha Hämäläinen; Erkki Isometsä; Sinikka Sihvo; Olli Kiviruusu; Sami Pirkola; Jouko Lönnqvist
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 140 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.20524
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Our objective was to assess the effectiveness and safety of the combination of duloxetine and bupropion for treatment-resistant major depressive disorder (TRD). A retrospective chart review was conducted to identify patients with major depressive disorder (MDD) who had not experienced full remission
Eight patients suering from major depression were treated with trazodone 150 or 200 mg bid (non-responders) over 5 weeks, preceded and followed by a placebo week. Cognitive functioning was tested in the morning at the end of each treatment week. Before trazodone treatment commenced, patients' cognit
## Abstract Many patients who have obsessive‐compulsive disorder (OCD) also meet criteria for additional diagnoses such as mood, anxiety, and personality disorders. The presence of severe depression, and major depressive disorder per se, impedes response to treatment for OCD that uses the best avai